UTHR United Therapeutics Corporation | US91307C1027
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 26.318.925.824 | 24.997.796.291,18 | 21.265.132.146,25 | 17.985.289.967,18 |
| Enterprise Value | 20.278.124.544 | 23.718.096.291,18 | 19.708.032.146,25 | 16.645.189.967,18 |
| Trailing P/E | 19,54 | 19,42 | 15,93 | 18,53 |
| Forward P/E | 16 | - | - | - |
| Price to Sales | 8,3 | 7,89 | 6,68 | 7,52 |
| Price to Book | 3,78 | 4,24 | 3 | 2,73 |
| EV/Revenue | 6,4 | 7,48 | 6,19 | 6,96 |
| EV/EBITDA | 13,1 | 13,66 | 10,7 | 12,14 |